What You Should Know:
- Densitas®, a provider of artificial intelligence solutions for breast cancer screening, announced a strategic partnership with Intelerad Medical Systems®, a provider of medical imaging software and services to advance AI-driven breast cancer screening.
- This partnership strengthens clinical decision-making, increases operational efficiencies, reduces costs, and improves mammography quality and mammography facility adherence with MQSA EQUIP
Read More
Breast Cancer
Ibex Launches Breast Cancer Biomarker Diagnostic Platform
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker scoring solution to aid pathologists with reproductible HER2 assessment for breast cancer. The platform allows clinicians to rapidly and accurately identify patients with HER2-low who would benefit from
Read More
Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care
What You Should Know:
- A recent study published in JAMA found that conventional genomic tests commonly used for breast cancer tumors can be less accurate for Black women. This news comes at a time when Black women with breast cancer are experiencing mortality rates that are 41% higher than white women.
- Dr. Nathalie Johnson, MD FACS and President of The American Society of Breast Cancer Surgeons is among numerous doctors who advocate for Agendia and its tests which look beyond race,
Read More
Maribel Health Raises $25M to Create the Future of Advanced Care at Home
What You Should Know:
- Maribel Health, a turnkey partner for health systems looking to design, build, and operate a full continuum of advanced home and community services, announced today the completion of a $25 million Series A funding round led by General Catalyst.
- The new funding will be used to accelerate growth with Maribel's initial partners, to attract and onboard the talent required to serve its collaborators worldwide and to support continued
Read More
H1 Launches Advanced Diversity and Clinical Trial Performance Insights
What You Should Know:
- H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution.
- Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More
Why Researchers Should Explore New Apps of Machine Learning
As the amount of real-world data (RWD) in the pharmaceutical industry continues to grow, so does the usage of machine learning (ML) to analyze that data and gain insights. In fact, in a recent survey, 95% of life sciences executives said they expect to utilize ML in the next few years to generate real-world evidence (RWE) from this data.
With such a large and growing volume of data available, researchers may be wondering how they can take advantage of all of it to enhance and expand the
Read More
5 Key Trends in Women’s Health Technology for 2023 to Watch
Women's healthcare faces an uphill battle after centuries of being ignored. Yet, ironically enough, women currently share half of the consumerism market, hold power over 80% of household financial decisions, and make 70% of healthcare-related choices in their families.
Despite this, their access to proper healthcare often comes up short.
But with the market for women's healthcare predicted to be worth over $47 billion, changes are starting to occur. And with the recent attacks and laws on
Read More
Biden Admin Builds on Cancer Moonshot with 13 More Initiatives
What You Should Know:
- One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today.
- The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More
Praying For The Survival of the NHS Will Not Be Enough To Save It
It’s often said that the National Health Service is the closest thing Britain has to a unifying religion. If that is the case, then the faith of the population is being tested like never before,
With budgets already stretched before the COVID pandemic, additional cost pressures since heaped on health boards across the country by double-digit inflation have brought the NHS closer to breaking point than at any time in its history.
Every passing day seems to bring bleaker news for the
Read More
Medical Natural Language Processing Tech Has Come of Age
For many years, natural language processing (NLP) has held the promise of dramatically increasing the ability of healthcare organizations to quickly and accurately understand unstructured medical text in clinical notes. Using medical NLP, healthcare providers, clinical researchers, and payers would uncover meaningful insights hidden in unstructured text faster, with fewer errors, and at less cost than manual data review and analysis. This high-quality medical-grade data in turn would drive
Read More
